Order results by:
Issue | Title | |
Vol 3, No 2 (2011) | Use of cereton in neurological care | Abstract similar documents |
Yu. A. Starchina | ||
"... . It analyzes the possibilities of using cereton (choline alphoscerate) made in Russia to treat cerebrovascular ..." | ||
Vol 2, No 2 (2010) | Clinical experience in using cereton in ischemic stroke and dyscirculatory encephalopathy | Abstract similar documents |
L. P. Ponomareva, N. F. Timoshkina, L. N. Sarantseva, A. A. Bulanov | ||
"... with cerebrovascular pathology. Choline alfoscerate (Cereton) manufactured by the Sotex pharmaceutical company ..." | ||
Vol 2, No 4 (2010) | Experience in using ceretone (choline alfoscerate) in brain concussion | Abstract similar documents |
N. G. Voropay, O. B. Doronina, B. M. Doronin | ||
"... , изучена эффективность церетона® (холина альфосцерата). 39 пациентов получали церетон® внутривенно в дозе ..." | ||
Vol 10, No 1 (2018) | Headache in elderly patients with chronic cerebral ischemia: outpatient diagnosis and treatment | Abstract similar documents |
M. P. Platov, O. V. Kosivtsova | ||
"... discusses the use of choline alphoscerate in patients diagnosed with CCI. ..." | ||
Vol 15, No 6 (2023) | Choline alfoscerate in the correction of cognitive impairment | Abstract similar documents |
O. A. Shavlovskaya, I. D. Romanov, I. A. Bokova | ||
"... В доклинических и клинических исследованиях холина альфосцерат (ХА) продемонстрировал высокую ..." | ||
Vol 16, No 6 (2024) | Management of patients with cognitive impairment in old age | Abstract similar documents |
D. A. Grishina, A. B. Lokshina, E. A. Sokolov | ||
"... современной нейропротекторной и симптоматической терапии КН, место холина альфосцерата в лечении УКН и ..." | ||
Vol 15, No 1 (2023) | Management of patients with cognitive impairment | Abstract similar documents |
V. A. Parfenov | ||
"... применение холина альфосцерата при КН, результаты многоцентрового плацебоконтролируемого исследования ..." | ||
Vol 17, No 3 (2025) | Opportunities for differential diagnosis of vascular cognitive impairment and Alzheimer's disease at the predementia stage | Abstract similar documents |
D. A. Grishina, A. B. Lokshina, E. A. Metelkina | ||
"... холина альфосцерата и цитиколина в лечении КН. Обсуждаются вопросы повышения приверженности пациентов ..." | ||
Vol 17, No 3 (2025) | Cognitive impairment in patients with chronic cerebral ischemia (discirculatory encephalopathy) | Abstract similar documents |
V. A. Parfenov, E. V. Silina | ||
"... безопасность применения холина альфосцерата у пациентов с БА и с цереброваскулярным заболеванием. ..." | ||
Vol 4, No 1S (2012): Special issue "Epilepsy" | Clinical and electroencephalographic polymorphism of malignant migrating partial seizures in infancy | Abstract similar documents |
A. A. Kholin | ||
Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
"... КН у больных, перенесших COVID-19, c применением Холитилина (холина альфосцерата) и комбинированного ..." | ||
Vol 9, No 4 (2017) | Geriatric information analysis of the molecular properties of mexidole | Abstract similar documents |
O. A. Gromova, I. Yu. Torshin, L. E. Fedotova | ||
"... возможных эффектов молекул мексидола, холина альфосцерата, пирацетама, глицина, семакса в соответствии с ..." | ||
Vol 5, No 1S (2013): Special issue "Epilepsy" | Epilepsy and autism: The authors’ study data | Abstract similar documents |
K. V. Voronkova, O. A. Pylayeva, A. A. Kholin, G. S. Golosnaya, T. V. Ananyeva, A. S. Petrukhin | ||
Vol 13, No 2 (2021) | Chemoreactom analysis of cytidyldiphosphocholine indicates synergistic combinations of neuroprotective agents | Abstract similar documents |
I. Yu. Torshin, O. A. Gromova, L. A. Mayorova, T. R. Grishina, L. E. Fedotova, A. N. Gromov, I. S. Sardaryan | ||
"... -холина) с другими средствами, используемыми в терапии хронической ишемии головного мозга. Материал и ..." | ||
Vol 7, No 4 (2015) | Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use | Abstract similar documents |
N. V. Trofimova, I. S. Preobrazhenskaya | ||
"... предшественником фосфолипидов, главным образом фосфатидилхолина, который служит источником холина в метаболических ..." | ||
Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | Magnetic resonance spectroscopy of the brain in the diagnosis of temporal lobe epilepsy | Abstract similar documents |
E. S. Solomatova, N. A. Shnaider, A. A. Molgachev, D. V. Dmitrenko, I. G. Strotskaya | ||
"... уровня N-ацетиласпартата (NAA), отношение NAA к креатину + холину (NAA/(Cr+Cho)) в той области головного ..." | ||
1 - 16 of 16 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)